Dataset | Score | p-value 1 | p-value 2 | p-value 3 |
---|---|---|---|---|
chia-screen-data-Fav | 2.975 | 4.80e-17 | 8.20e-05 | 9.64e-04 |
Gene Symbol | Entrez Gene ID | Frequency | chia-screen-data-Fav gene score | Best subnetwork score | Degree | Chia-Hits Primary | Chia-Hits Secondary |
---|---|---|---|---|---|---|---|
TUBB4A | 10382 | 7 | -2.312 | 2.975 | 88 | Yes | - |
PSMD2 | 5708 | 47 | -4.172 | 3.157 | 386 | Yes | Yes |
LARS | 51520 | 14 | -2.574 | 3.157 | 105 | Yes | Yes |
TCP1 | 6950 | 10 | -2.383 | 3.119 | 241 | Yes | - |
GLUD1 | 2746 | 1 | -2.295 | 2.975 | 49 | Yes | - |
POU5F1 | 5460 | 133 | -5.148 | 3.538 | 179 | Yes | Yes |
DDIT3 | 1649 | 60 | -2.825 | 3.504 | 343 | Yes | Yes |
[ MAP3K1 ] | 4214 | 3 | -2.088 | 2.975 | 123 | Yes | - |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
MAP3K1 | 4214 | TCP1 | 6950 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, MINT; int.Mint: MI:0915(physical association) |
GLUD1 | 2746 | LARS | 51520 | pp | -- | int.I2D: BioGrid_Yeast, Krogan_Core, MINT_Yeast |
GLUD1 | 2746 | MAP3K1 | 4214 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, MINT; int.Mint: MI:0915(physical association) |
DDIT3 | 1649 | TCP1 | 6950 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
POU5F1 | 5460 | TUBB4A | 10382 | pp | -- | int.I2D: BioGrid |
PSMD2 | 5708 | TCP1 | 6950 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, YeastLow |
DDIT3 | 1649 | TUBB4A | 10382 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
PSMD2 | 5708 | LARS | 51520 | pp | -- | int.I2D: BioGrid_Yeast |
MAP3K1 | 4214 | TUBB4A | 10382 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, MINT; int.Mint: MI:0915(physical association) |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 2.09e-05 | 3.02e-01 | 8.116 | 2 | 2 | 13 |
GO:0005829 | cytosol | 3.14e-05 | 4.52e-01 | 2.338 | 7 | 86 | 2496 |
GO:0051084 | 'de novo' posttranslational protein folding | 1.78e-04 | 1.00e+00 | 6.607 | 2 | 5 | 37 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:2000016 | negative regulation of determination of dorsal identity | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0005515 | protein binding | 9.24e-04 | 1.00e+00 | 1.260 | 8 | 198 | 6024 |
GO:0006429 | leucyl-tRNA aminoacylation | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0004352 | glutamate dehydrogenase (NAD+) activity | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0009786 | regulation of asymmetric cell division | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0004823 | leucine-tRNA ligase activity | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0004353 | glutamate dehydrogenase [NAD(P)+] activity | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0044324 | regulation of transcription involved in anterior/posterior axis specification | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0072350 | tricarboxylic acid metabolic process | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0008545 | JUN kinase kinase activity | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0060913 | cardiac cell fate determination | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0044267 | cellular protein metabolic process | 1.75e-03 | 1.00e+00 | 3.512 | 3 | 20 | 474 |
GO:0007021 | tubulin complex assembly | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:0070728 | leucine binding | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:0033269 | internode region of axon | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:0006538 | glutamate catabolic process | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:0006457 | protein folding | 2.63e-03 | 1.00e+00 | 4.656 | 2 | 7 | 143 |
GO:0001714 | endodermal cell fate specification | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 5 |
GO:0006537 | glutamate biosynthetic process | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 5 |
GO:0043620 | regulation of DNA-templated transcription in response to stress | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 5 |
GO:0005524 | ATP binding | 3.40e-03 | 1.00e+00 | 2.474 | 4 | 31 | 1298 |
GO:0044212 | transcription regulatory region DNA binding | 3.61e-03 | 1.00e+00 | 4.424 | 2 | 17 | 168 |
GO:0034641 | cellular nitrogen compound metabolic process | 3.73e-03 | 1.00e+00 | 4.398 | 2 | 2 | 171 |
GO:0002161 | aminoacyl-tRNA editing activity | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 2 | 7 |
GO:0001955 | blood vessel maturation | 4.43e-03 | 1.00e+00 | 7.816 | 1 | 1 | 8 |
GO:0006983 | ER overload response | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 9 |
GO:0006450 | regulation of translational fidelity | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 2 | 9 |
GO:0003382 | epithelial cell morphogenesis | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 9 |
GO:0005832 | chaperonin-containing T-complex | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 2 | 9 |
GO:0002199 | zona pellucida receptor complex | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 2 | 10 |
GO:0035413 | positive regulation of catenin import into nucleus | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 2 | 10 |
GO:0061029 | eyelid development in camera-type eye | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 2 | 10 |
GO:0070403 | NAD+ binding | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 1 | 11 |
GO:0045662 | negative regulation of myoblast differentiation | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 3 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 4 | 11 |
GO:0005838 | proteasome regulatory particle | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 12 |
GO:0035198 | miRNA binding | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 12 |
GO:0030234 | enzyme regulator activity | 7.19e-03 | 1.00e+00 | 7.116 | 1 | 2 | 13 |
GO:0008134 | transcription factor binding | 7.34e-03 | 1.00e+00 | 3.897 | 2 | 18 | 242 |
GO:0000242 | pericentriolar material | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 1 | 14 |
GO:0005874 | microtubule | 7.76e-03 | 1.00e+00 | 3.856 | 2 | 7 | 249 |
GO:0001824 | blastocyst development | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 2 | 15 |
GO:0042176 | regulation of protein catabolic process | 8.84e-03 | 1.00e+00 | 6.816 | 1 | 2 | 16 |
GO:0043209 | myelin sheath | 8.84e-03 | 1.00e+00 | 6.816 | 1 | 1 | 16 |
GO:0006541 | glutamine metabolic process | 9.39e-03 | 1.00e+00 | 6.729 | 1 | 2 | 17 |
GO:0008652 | cellular amino acid biosynthetic process | 9.39e-03 | 1.00e+00 | 6.729 | 1 | 1 | 17 |
GO:0022624 | proteasome accessory complex | 9.39e-03 | 1.00e+00 | 6.729 | 1 | 1 | 17 |
GO:0004709 | MAP kinase kinase kinase activity | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 2 | 18 |
GO:0032757 | positive regulation of interleukin-8 production | 1.10e-02 | 1.00e+00 | 6.494 | 1 | 1 | 20 |
GO:0008637 | apoptotic mitochondrial changes | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 2 | 21 |
GO:0005525 | GTP binding | 1.18e-02 | 1.00e+00 | 3.540 | 2 | 12 | 310 |
GO:0005720 | nuclear heterochromatin | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 2 | 22 |
GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 1.27e-02 | 1.00e+00 | 6.293 | 1 | 1 | 23 |
GO:0007339 | binding of sperm to zona pellucida | 1.38e-02 | 1.00e+00 | 6.172 | 1 | 2 | 25 |
GO:0051209 | release of sequestered calcium ion into cytosol | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 1 | 26 |
GO:0043565 | sequence-specific DNA binding | 1.46e-02 | 1.00e+00 | 3.381 | 2 | 11 | 346 |
GO:0007017 | microtubule-based process | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 2 | 27 |
GO:0051258 | protein polymerization | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 2 | 27 |
GO:0043531 | ADP binding | 1.54e-02 | 1.00e+00 | 6.009 | 1 | 3 | 28 |
GO:0042594 | response to starvation | 1.71e-02 | 1.00e+00 | 5.862 | 1 | 4 | 31 |
GO:0005654 | nucleoplasm | 1.77e-02 | 1.00e+00 | 2.322 | 3 | 64 | 1082 |
GO:0032024 | positive regulation of insulin secretion | 1.82e-02 | 1.00e+00 | 5.772 | 1 | 3 | 33 |
GO:0000278 | mitotic cell cycle | 1.84e-02 | 1.00e+00 | 3.205 | 2 | 15 | 391 |
GO:0030838 | positive regulation of actin filament polymerization | 1.87e-02 | 1.00e+00 | 5.729 | 1 | 1 | 34 |
GO:0007257 | activation of JUN kinase activity | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 5 | 36 |
GO:0035019 | somatic stem cell maintenance | 2.20e-02 | 1.00e+00 | 5.494 | 1 | 6 | 40 |
GO:0006418 | tRNA aminoacylation for protein translation | 2.31e-02 | 1.00e+00 | 5.424 | 1 | 3 | 42 |
GO:0021762 | substantia nigra development | 2.42e-02 | 1.00e+00 | 5.357 | 1 | 4 | 44 |
GO:0043525 | positive regulation of neuron apoptotic process | 2.52e-02 | 1.00e+00 | 5.293 | 1 | 4 | 46 |
GO:0044297 | cell body | 2.52e-02 | 1.00e+00 | 5.293 | 1 | 2 | 46 |
GO:0001669 | acrosomal vesicle | 2.69e-02 | 1.00e+00 | 5.201 | 1 | 2 | 49 |
GO:0006521 | regulation of cellular amino acid metabolic process | 2.74e-02 | 1.00e+00 | 5.172 | 1 | 1 | 50 |
GO:0006986 | response to unfolded protein | 2.74e-02 | 1.00e+00 | 5.172 | 1 | 4 | 50 |
GO:0030334 | regulation of cell migration | 2.74e-02 | 1.00e+00 | 5.172 | 1 | 5 | 50 |
GO:0034976 | response to endoplasmic reticulum stress | 2.79e-02 | 1.00e+00 | 5.144 | 1 | 2 | 51 |
GO:0045454 | cell redox homeostasis | 2.79e-02 | 1.00e+00 | 5.144 | 1 | 1 | 51 |
GO:0009611 | response to wounding | 2.85e-02 | 1.00e+00 | 5.116 | 1 | 5 | 52 |
GO:0000186 | activation of MAPKK activity | 2.96e-02 | 1.00e+00 | 5.061 | 1 | 2 | 54 |
GO:0000502 | proteasome complex | 3.17e-02 | 1.00e+00 | 4.958 | 1 | 3 | 58 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 3.23e-02 | 1.00e+00 | 4.933 | 1 | 6 | 59 |
GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 3.33e-02 | 1.00e+00 | 4.885 | 1 | 2 | 61 |
GO:0042060 | wound healing | 3.50e-02 | 1.00e+00 | 4.816 | 1 | 2 | 64 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 3.50e-02 | 1.00e+00 | 4.816 | 1 | 1 | 64 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 2 | 65 |
GO:0034146 | toll-like receptor 5 signaling pathway | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 4 | 65 |
GO:0071260 | cellular response to mechanical stimulus | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 4 | 65 |
GO:0034166 | toll-like receptor 10 signaling pathway | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 4 | 65 |
GO:0010468 | regulation of gene expression | 3.71e-02 | 1.00e+00 | 4.729 | 1 | 2 | 68 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 3.82e-02 | 1.00e+00 | 4.687 | 1 | 2 | 70 |
GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway | 3.87e-02 | 1.00e+00 | 4.666 | 1 | 4 | 71 |
GO:0038124 | toll-like receptor TLR6:TLR2 signaling pathway | 3.87e-02 | 1.00e+00 | 4.666 | 1 | 4 | 71 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 3.93e-02 | 1.00e+00 | 4.646 | 1 | 1 | 72 |
GO:0034162 | toll-like receptor 9 signaling pathway | 3.93e-02 | 1.00e+00 | 4.646 | 1 | 4 | 72 |
GO:0034134 | toll-like receptor 2 signaling pathway | 3.98e-02 | 1.00e+00 | 4.626 | 1 | 4 | 73 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 4.03e-02 | 1.00e+00 | 4.607 | 1 | 4 | 74 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 4.03e-02 | 1.00e+00 | 4.607 | 1 | 2 | 74 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 4.09e-02 | 1.00e+00 | 4.587 | 1 | 1 | 75 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 4.09e-02 | 1.00e+00 | 4.587 | 1 | 1 | 75 |
GO:0005929 | cilium | 4.19e-02 | 1.00e+00 | 4.549 | 1 | 2 | 77 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 4.30e-02 | 1.00e+00 | 4.512 | 1 | 2 | 79 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 4.30e-02 | 1.00e+00 | 4.512 | 1 | 2 | 79 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 4.35e-02 | 1.00e+00 | 4.494 | 1 | 5 | 80 |
GO:0009653 | anatomical structure morphogenesis | 4.51e-02 | 1.00e+00 | 4.441 | 1 | 2 | 83 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 4.67e-02 | 1.00e+00 | 4.390 | 1 | 8 | 86 |
GO:0005200 | structural constituent of cytoskeleton | 4.94e-02 | 1.00e+00 | 4.308 | 1 | 6 | 91 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 4.99e-02 | 1.00e+00 | 4.293 | 1 | 1 | 92 |
GO:0010467 | gene expression | 4.99e-02 | 1.00e+00 | 2.430 | 2 | 45 | 669 |
GO:0005770 | late endosome | 5.04e-02 | 1.00e+00 | 4.277 | 1 | 2 | 93 |
GO:0051082 | unfolded protein binding | 5.04e-02 | 1.00e+00 | 4.277 | 1 | 7 | 93 |
GO:0034142 | toll-like receptor 4 signaling pathway | 5.20e-02 | 1.00e+00 | 4.231 | 1 | 4 | 96 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 5.41e-02 | 1.00e+00 | 2.367 | 2 | 39 | 699 |
GO:0002224 | toll-like receptor signaling pathway | 5.89e-02 | 1.00e+00 | 4.048 | 1 | 4 | 109 |
GO:0000209 | protein polyubiquitination | 6.26e-02 | 1.00e+00 | 3.958 | 1 | 3 | 116 |
GO:0007050 | cell cycle arrest | 6.68e-02 | 1.00e+00 | 3.862 | 1 | 5 | 124 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 6.72e-02 | 1.00e+00 | 2.192 | 2 | 41 | 789 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 6.88e-02 | 1.00e+00 | 3.816 | 1 | 11 | 128 |
GO:0000086 | G2/M transition of mitotic cell cycle | 7.30e-02 | 1.00e+00 | 3.729 | 1 | 4 | 136 |
GO:0016055 | Wnt signaling pathway | 7.40e-02 | 1.00e+00 | 3.708 | 1 | 4 | 138 |
GO:0000082 | G1/S transition of mitotic cell cycle | 7.97e-02 | 1.00e+00 | 3.597 | 1 | 3 | 149 |
GO:0042981 | regulation of apoptotic process | 8.03e-02 | 1.00e+00 | 3.587 | 1 | 4 | 150 |
GO:0006974 | cellular response to DNA damage stimulus | 8.08e-02 | 1.00e+00 | 3.578 | 1 | 7 | 151 |
GO:0038095 | Fc-epsilon receptor signaling pathway | 8.95e-02 | 1.00e+00 | 3.424 | 1 | 5 | 168 |
GO:0005667 | transcription factor complex | 9.31e-02 | 1.00e+00 | 3.365 | 1 | 17 | 175 |
GO:0004672 | protein kinase activity | 9.41e-02 | 1.00e+00 | 3.348 | 1 | 3 | 177 |
GO:0031625 | ubiquitin protein ligase binding | 9.46e-02 | 1.00e+00 | 3.340 | 1 | 5 | 178 |
GO:0003714 | transcription corepressor activity | 9.46e-02 | 1.00e+00 | 3.340 | 1 | 11 | 178 |
GO:0006355 | regulation of transcription, DNA-templated | 1.01e-01 | 1.00e+00 | 1.855 | 2 | 43 | 997 |
GO:0003924 | GTPase activity | 1.04e-01 | 1.00e+00 | 3.194 | 1 | 7 | 197 |
GO:0044822 | poly(A) RNA binding | 1.12e-01 | 1.00e+00 | 1.772 | 2 | 50 | 1056 |
GO:0006184 | GTP catabolic process | 1.13e-01 | 1.00e+00 | 3.075 | 1 | 7 | 214 |
GO:0016071 | mRNA metabolic process | 1.17e-01 | 1.00e+00 | 3.015 | 1 | 8 | 223 |
GO:0005759 | mitochondrial matrix | 1.20e-01 | 1.00e+00 | 2.983 | 1 | 4 | 228 |
GO:0043025 | neuronal cell body | 1.28e-01 | 1.00e+00 | 2.879 | 1 | 9 | 245 |
GO:0016070 | RNA metabolic process | 1.29e-01 | 1.00e+00 | 2.868 | 1 | 8 | 247 |
GO:0070062 | extracellular vesicular exosome | 1.34e-01 | 1.00e+00 | 1.172 | 3 | 57 | 2400 |
GO:0044281 | small molecule metabolic process | 1.41e-01 | 1.00e+00 | 1.574 | 2 | 20 | 1211 |
GO:0003677 | DNA binding | 1.42e-01 | 1.00e+00 | 1.566 | 2 | 49 | 1218 |
GO:0019901 | protein kinase binding | 1.63e-01 | 1.00e+00 | 2.508 | 1 | 18 | 317 |
GO:0005813 | centrosome | 1.67e-01 | 1.00e+00 | 2.467 | 1 | 7 | 326 |
GO:0046982 | protein heterodimerization activity | 1.92e-01 | 1.00e+00 | 2.246 | 1 | 8 | 380 |
GO:0045892 | negative regulation of transcription, DNA-templated | 2.07e-01 | 1.00e+00 | 2.126 | 1 | 24 | 413 |
GO:0006366 | transcription from RNA polymerase II promoter | 2.10e-01 | 1.00e+00 | 2.105 | 1 | 30 | 419 |
GO:0055114 | oxidation-reduction process | 2.11e-01 | 1.00e+00 | 2.102 | 1 | 10 | 420 |
GO:0043066 | negative regulation of apoptotic process | 2.12e-01 | 1.00e+00 | 2.088 | 1 | 16 | 424 |
GO:0005634 | nucleus | 2.24e-01 | 1.00e+00 | 0.662 | 4 | 159 | 4559 |
GO:0006468 | protein phosphorylation | 2.28e-01 | 1.00e+00 | 1.971 | 1 | 10 | 460 |
GO:0045893 | positive regulation of transcription, DNA-templated | 2.36e-01 | 1.00e+00 | 1.915 | 1 | 24 | 478 |
GO:0042802 | identical protein binding | 2.39e-01 | 1.00e+00 | 1.897 | 1 | 19 | 484 |
GO:0016032 | viral process | 2.61e-01 | 1.00e+00 | 1.755 | 1 | 26 | 534 |
GO:0006915 | apoptotic process | 2.69e-01 | 1.00e+00 | 1.700 | 1 | 12 | 555 |
GO:0045087 | innate immune response | 2.87e-01 | 1.00e+00 | 1.597 | 1 | 15 | 596 |
GO:0005794 | Golgi apparatus | 2.92e-01 | 1.00e+00 | 1.563 | 1 | 9 | 610 |
GO:0005737 | cytoplasm | 3.49e-01 | 1.00e+00 | 0.522 | 3 | 124 | 3767 |
GO:0008270 | zinc ion binding | 4.36e-01 | 1.00e+00 | 0.855 | 1 | 27 | 997 |
GO:0005739 | mitochondrion | 4.37e-01 | 1.00e+00 | 0.853 | 1 | 23 | 998 |
GO:0016020 | membrane | 6.29e-01 | 1.00e+00 | 0.101 | 1 | 46 | 1681 |